S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
PSNL · Personalis, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Personalis Inc (PSNL)
NASDAQ NMS - GLOBAL MARKET
Life Sciences Tools & Services
$15.89
-0.05
(-0.31%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$15.89
$15.78
$16.11
52-WEEK RANGE
$15.89
$4.96
$18.89
What's happening
- PSNL is down 0.31% today, trading at $15.89. — Live quote
- Volume today (235,781) is well below its 3-month average of 3,551,990. (Finnhub fundamentals)
- Reports earnings on 2026-11-10, 19 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.30 actual vs. $-0.27 estimated (-13.2%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 4
Buy 3
Hold 4
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (11 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
PSNL
+100.25%
vs S&P 500
+87.47%
1-YEAR RETURN
PSNL
+57.51%
vs S&P 500
+42.95%
6-MONTH RETURN
PSNL
+139.34%
3-MONTH RETURN
PSNL
+18.60%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.30
Est. $-0.27
MISS -13.2%
2026-04-26 (Q1 2026)
$-0.29
Est. $-0.28
MISS -5.4%
2026-01-26 (Q4 2025)
$-0.26
Est. $-0.30
BEAT +13.0%
2025-10-26 (Q3 2025)
$-0.24
Est. $-0.28
BEAT +15.6%
Valuation Measures & Ratios
Enterprise Value4$1.61B
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)24.47
Price / Book75.97
EV4 / Revenue23.13
EV4 / EBITDA—
Profit Margin-153.84%
Operating Margin-164.07%
Return on Equity (ROE8)-46.47%
Return on Assets (ROA9)-35.30%
Avg Volume (3M)3,551,990
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $1.42B | $659.2M | $588.7M | $572.0M | $306.2M |
| P/E | -13.68 | -7.53 | -6.10 | -6.52 | -3.80 |
| Price/Sales | 20.35 | 9.73 | 7.55 | 6.64 | 3.46 |
| Price/Book | 6.02 | 2.59 | 3.43 | 3.00 | 1.48 |
| EV/Revenue | 19.00 | 8.64 | 6.91 | 6.02 | 2.66 |
| EV/EBITDA | -13.07 | -6.89 | -8.41 | — | — |
| ROE | -43.98% | -34.34% | -56.32% | -45.96% | -38.88% |
| ROA | -33.13% | -26.89% | -39.76% | -33.90% | -29.49% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short8,427,731
Change from Prior Settlement+1.95%
% of Float—
Days to Cover (Short Ratio)4.33
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 30.0% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +57.5%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is -153.8%. Finnhub fundamentals ↗
- Latest SEC filing is Form 8-K, filed 2026-10-06; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on PSNL
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22.4M | $15.5M | $14.5M | $17.2M | $20.6M | $25.7M | $22.6M | $19.5M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$33.6M | -$32.2M | -$23.3M | -$21.8M | -$17.7M | -$14.4M | -$16.9M | -$18.9M |
| Net income | -$31.7M | -$30.0M | -$21.7M | -$20.1M | -$15.8M | -$39.1M | -$12.8M | -$13.0M |
| EPS (diluted) | $-0.30 | $-0.29 | $-0.24 | $-0.23 | $-0.18 | $-0.64 | $-0.24 | $-0.26 |
| EPS (basic) | $-0.30 | $-0.29 | $-0.24 | $-0.23 | $-0.18 | $-0.64 | $-0.24 | $-0.26 |
| Operating margin | -$150 | -$208 | -$161 | -$127 | -$86 | -$56 | -$75 | -$97 |
| Net margin | -$142 | -$194 | -$149 | -$117 | -$76 | -$152 | -$57 | -$66 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $312.1M | $325.4M | $334.2M | $242.8M | $258.7M | $273.3M | $270.3M | $239.9M |
| Total liabilities | $77.0M | $70.6M | $73.0M | $71.4M | $67.9M | $66.0M | $67.3M | $73.1M |
| Stockholders' equity | $235.2M | $254.8M | $261.2M | $171.4M | $190.8M | $207.3M | $203.0M | $166.8M |
| Total current assets | $245.1M | $258.2M | $268.0M | $174.4M | $193.3M | $206.4M | $203.0M | $170.3M |
| Total current liabilities | $46.4M | $39.0M | $39.6M | $36.2M | $31.7M | $29.9M | $31.1M | $36.4M |
| Cash & equivalents | $94.0M | $73.6M | $124.2M | $50.0M | $53.4M | $71.0M | $91.4M | $75.8M |
| Marketable securities (current) | $118.7M | $159.6M | $115.7M | $100.5M | $119.9M | $114.7M | $93.6M | $67.9M |
| Accounts receivable | $15.1M | $13.0M | $16.2M | $14.4M | $10.0M | $11.0M | $8.1M | $13.5M |
| Property, plant & equipment | $48.6M | $48.4M | $44.8M | $47.0M | $45.8M | $48.0M | $48.3M | $50.2M |
| Other non-current assets | $3.7M | $3.8M | $6.3M | $6.2M | $3.9M | $2.8M | $2.5M | $2.6M |
| Accounts payable | $16.0M | $12.7M | $13.0M | $11.1M | $9.9M | $7.9M | $6.4M | $12.4M |
| Accrued liabilities | — | — | — | — | — | — | — | $1.5M |
| Deferred revenue (current) | $3.4M | $4.2M | $1.6M | $1.5M | $1.6M | $2.0M | $3.1M | $3.4M |
| Short-term debt | — | — | — | — | — | — | — | — |
| Other current liabilities | $6.7M | $4.8M | $5.5M | $4.1M | $1.5M | $1.7M | $2.0M | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Other non-current liabilities | $422.0K | $562.0K | $1.5M | $2.6M | $2.7M | $2.0M | $1.3M | $1.1M |
| Retained earnings | -$693.0M | -$661.3M | -$631.3M | -$607.4M | -$585.8M | -$565.7M | -$550.0M | -$533.6M |
| Accumulated other comprehensive income (loss) | -$118.0K | -$70.0K | $104.0K | $82.0K | $20.0K | -$18.0K | -$23.0K | $87.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$25.8M | -$22.5M | -$22.2M | -$21.8M | -$12.9M | -$18.0M | -$7.8M | -$6.2M |
| Investing cash flow | $38.2M | -$46.0M | -$14.4M | $18.7M | -$4.4M | -$22.5M | -$26.2M | -$28.2M |
| Financing cash flow | $8.0M | $17.8M | $110.9M | -$317.0K | -$327.0K | $20.1M | $49.6M | $62.4M |
| Free cash flow | -$29.6M | -$25.7M | -$22.3M | -$23.4M | -$13.2M | -$20.5M | -$9.0M | -$6.4M |
| Capital expenditures | $3.8M | $3.2M | $77.0K | $1.6M | $290.0K | $2.5M | $1.2M | $247.0K |
| Depreciation & amortization | $2.4M | $2.4M | $2.5M | $2.5M | $2.5M | $2.6M | $2.5M | $5.6M |
| Share-based compensation | $4.0M | $2.6M | $2.3M | $2.1M | $2.8M | $2.2M | $2.7M | $2.7M |
| Deferred income taxes | — | — | -$2.0K | — | — | — | -$1.0K | — |
| Change in accounts receivable | $2.1M | -$3.2M | $1.8M | $4.4M | -$1.0M | $2.8M | -$5.3M | $554.0K |
| Change in accounts payable | $4.6M | -$809.0K | $1.8M | -$990.0K | $1.7M | $2.0M | -$4.8M | $966.0K |
| Purchases of investments | $27.2M | $67.0M | $53.7M | $48.1M | $44.0M | $64.3M | $44.9M | $38.9M |
| Sales/maturities of investments | $69.1M | $24.1M | $39.4M | $68.5M | $39.9M | $44.2M | $20.0M | $11.0M |
| Other financing activities | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $69.6M | $84.6M | $73.5M | $65.0M | $85.5M |
| Operating income | -$88.1M | -$68.3M | -$109.9M | -$115.5M | -$65.4M |
| Net income | -$81.3M | -$81.3M | -$108.3M | -$113.3M | -$65.2M |
| EPS (diluted) | $-0.91 | $-1.37 | $-2.25 | $-2.48 | $-1.49 |
| EPS (basic) | $-0.91 | $-1.37 | $-2.25 | $-2.48 | $-1.49 |
| Operating margin | -$126 | -$81 | -$150 | -$178 | -$76 |
| Net margin | -$117 | -$96 | -$147 | -$174 | -$76 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $334.2M | $270.3M | $225.1M | $292.7M | $396.5M |
| Total liabilities | $73.0M | $67.3M | $95.7M | $74.6M | $86.2M |
| Stockholders' equity | $261.2M | $203.0M | $129.4M | $218.1M | $310.3M |
| Total current assets | $268.0M | $203.0M | $146.7M | $199.7M | $318.2M |
| Total current liabilities | $39.6M | $31.1M | $47.2M | $33.1M | $31.3M |
| Cash & equivalents | $124.2M | $91.4M | $57.0M | $89.1M | $105.6M |
| Marketable securities (current) | $115.7M | $93.6M | $57.2M | $78.5M | $181.5M |
| Accounts receivable | $16.2M | $8.1M | $17.7M | $16.6M | $18.5M |
| Property, plant & equipment | $44.8M | $48.3M | $57.4M | $61.9M | $19.6M |
| Other non-current assets | $6.3M | $2.5M | $3.1M | $4.6M | $4.8M |
| Accounts payable | $13.0M | $6.4M | $14.9M | $12.9M | $9.2M |
| Accrued liabilities | — | — | $858.0K | $1.7M | $883.0K |
| Deferred revenue (current) | $1.6M | $3.1M | $3.3M | $1.3M | $4.0M |
| Short-term debt | — | — | — | — | — |
| Other current liabilities | $5.5M | $2.0M | — | — | — |
| Other non-current liabilities | $1.5M | $1.3M | $5.2M | $389.0K | $2.1M |
| Retained earnings | -$631.3M | -$550.0M | -$468.7M | -$360.4M | -$247.1M |
| Accumulated other comprehensive income (loss) | $104.0K | -$23.0K | -$222.0K | -$912.0K | -$166.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$74.9M | -$45.1M | -$56.3M | -$70.2M | -$70.8M |
| Investing cash flow | -$22.6M | -$35.1M | $13.1M | $52.5M | -$60.1M |
| Financing cash flow | $130.3M | $114.7M | $11.0M | $1.4M | $169.7M |
| Free cash flow | -$79.5M | -$46.8M | -$67.2M | -$120.1M | -$81.9M |
| Capital expenditures | $4.5M | $1.6M | $10.9M | $49.9M | $11.1M |
| Depreciation & amortization | $10.0M | $10.9M | $11.3M | $8.4M | $6.0M |
| Share-based compensation | $9.4M | $10.7M | $14.1M | $19.4M | $14.4M |
| Deferred income taxes | -$2.0K | -$1.0K | $54.0K | -$31.0K | -$29.0K |
| Change in accounts receivable | $8.1M | -$9.6M | $1.1M | -$1.8M | $12.1M |
| Change in accounts payable | $4.5M | -$8.9M | $5.2M | $3.1M | -$1.5M |
| Purchases of investments | $210.2M | $121.7M | $103.9M | $121.5M | $267.1M |
| Sales/maturities of investments | $192.1M | $88.0M | $128.0M | $223.9M | $213.1M |
| Other financing activities | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding PSNL as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-03-15 to 2026-09-18
Recent transactions
- Insiders have net sold 551,488 shares over the last 182 days, across 0 purchases and 13 sales.
- Most recent: Moore Stephen Michael (SVP and Chief Legal Officer) — Open market sale of 2,068 shares on 2026-09-18.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)551,488 sh(13 txns)
Net Shares-551,488
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Moore Stephen Michael | SVP and Chief Legal Officer | Open market sale | 2026-09-18 | 2,068 |
| Chen Richard | President and CMO | Open market sale | 2026-09-18 | 3,998 |
| Hall Christopher M | Chief Executive Officer | Open market sale | 2026-09-18 | 7,459 |
| Tachibana Aaron | CFO AND COO | Open market sale | 2026-09-18 | 2,931 |
| EASTHAM KARIN | Reporting person | Grant / award | 2026-05-12 | 6,250 |
| BOWMAN A BLAINE | Reporting person | Grant / award | 2026-05-12 | 6,250 |
| WIDDER KENNETH J | Reporting person | Grant / award | 2026-05-12 | 6,250 |
| Shoff Lonnie | Reporting person | Grant / award | 2026-05-12 | 6,250 |
| Bloom Olivia Kyusuk | Reporting person | Grant / award | 2026-05-12 | 6,250 |
| MYERS WOODROW A JR | Reporting person | Grant / award | 2026-05-12 | 6,250 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-18 | Moore Stephen Michael | SVP and Chief Legal Officer | Open market sale | 2,068 | $16.22 |
| 2026-09-18 | Chen Richard | President and CMO | Open market sale | 3,998 | $16.22 |
| 2026-09-18 | Hall Christopher M | Chief Executive Officer | Open market sale | 7,459 | $16.22 |
| 2026-09-18 | Tachibana Aaron | CFO AND COO | Open market sale | 2,931 | $16.22 |
| 2026-07-15 | Chen Richard | President and CMO | Option exercise | 100,000 | $2.44 |
| 2026-07-15 | Chen Richard | President and CMO | Open market sale | 100,000 | $15.15 |
| 2026-07-09 | Hall Christopher M | Chief Executive Officer | Option exercise | 100,000 | $1.61 |
| 2026-07-09 | Hall Christopher M | Chief Executive Officer | Open market sale | 100,000 | $15.08 |
| 2026-06-29 | Tachibana Aaron | CFO AND COO | Option exercise | 4,982 | $5.32 |
| 2026-06-29 | Tachibana Aaron | CFO AND COO | Open market sale | 4,982 | $14.00 |
| 2026-06-26 | Tachibana Aaron | CFO AND COO | Option exercise | 28,832 | $9.16 |
| 2026-06-26 | Tachibana Aaron | CFO AND COO | Option exercise | 22,419 | $5.32 |
| 2026-06-26 | Tachibana Aaron | CFO AND COO | Open market sale | 51,251 | $13.18 |
| 2026-06-26 | Hall Christopher M | Chief Executive Officer | Option exercise | 100,000 | $1.61 |
| 2026-06-26 | Hall Christopher M | Chief Executive Officer | Open market sale | 100,000 | $13.15 |
| 2026-06-04 | Tachibana Aaron | CFO AND COO | Option exercise | 40,000 | $9.16 |
| 2026-06-04 | Tachibana Aaron | CFO AND COO | Open market sale | 40,000 | $12.01 |
| 2026-05-29 | Hall Christopher M | Chief Executive Officer | Option exercise | 80,091 | $1.61 |
| 2026-05-29 | Hall Christopher M | Chief Executive Officer | Open market sale | 80,091 | $11.02 |
| 2026-05-29 | Tachibana Aaron | CFO AND COO | Option exercise | 38,799 | $9.16 |
| 2026-05-29 | Tachibana Aaron | CFO AND COO | Open market sale | 38,799 | $11.58 |
| 2026-05-28 | Hall Christopher M | Chief Executive Officer | Option exercise | 19,909 | $1.61 |
| 2026-05-28 | Hall Christopher M | Chief Executive Officer | Open market sale | 19,909 | $11.02 |
| 2026-05-12 | EASTHAM KARIN | Reporting person | Grant / award | 6,250 | $0.00 |
| 2026-05-12 | BOWMAN A BLAINE | Reporting person | Grant / award | 6,250 | $0.00 |
| 2026-05-12 | WIDDER KENNETH J | Reporting person | Grant / award | 6,250 | $0.00 |
| 2026-05-12 | Shoff Lonnie | Reporting person | Grant / award | 6,250 | $0.00 |
| 2026-05-12 | Bloom Olivia Kyusuk | Reporting person | Grant / award | 6,250 | $0.00 |
| 2026-05-12 | MYERS WOODROW A JR | Reporting person | Grant / award | 6,250 | $0.00 |
| 2026-03-15 | Tachibana Aaron | CFO AND COO | Grant / award | 34,375 | $0.00 |
| 2026-03-15 | Moore Stephen Michael | SVP and Chief Legal Officer | Grant / award | 28,125 | $0.00 |
| 2026-03-15 | Hall Christopher M | Chief Executive Officer | Grant / award | 87,500 | $0.00 |
| 2026-03-15 | Chen Richard | President and CMO | Grant / award | 46,875 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 04:17 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-06 | 8-K | 2026-10-02 | View on SEC.gov → |
| 2026-09-22 | 4 | 2026-09-18 | View on SEC.gov → |
| 2026-09-22 | 4 | 2026-09-18 | View on SEC.gov → |
| 2026-09-22 | 4 | 2026-09-18 | View on SEC.gov → |
| 2026-09-22 | 4 | 2026-09-18 | View on SEC.gov → |
| 2026-08-20 | 8-K | 2026-08-20 | View on SEC.gov → |
| 2026-08-04 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-04 | 8-K | 2026-08-04 | View on SEC.gov → |
| 2026-07-20 | 8-K | 2026-07-20 | View on SEC.gov → |
| 2026-07-20 | 8-K | 2026-07-20 | View on SEC.gov → |
| 2026-07-15 | 4 | 2026-07-15 | View on SEC.gov → |
| 2026-07-09 | 4 | 2026-07-09 | View on SEC.gov → |
Recent news
Headlines about PSNL (Personalis, Inc.). Links open the publisher — we don’t host full articles.
-
PSNL Stock Notification: Personalis, Inc. is being Investigated after the $16.25 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law
Business Wire · 2026-10-21 -
Personalis, Inc. (PSNL) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-21 -
Personalis NeXT Personal® Data Showcasing Ultrasensitive MRD to be Presented at ESMO 2026
Yahoo · 2026-10-21 -
No merger-related layoffs are anticipated by Personalis (PSNL) as Tempus takeover awaits closing.
Stock Titan · 2026-10-20 -
Personalis Brings Resistance Mutation Tracking to NeXT Personal® MRD Test
Yahoo · 2026-10-20 -
PSNL Jan 2027 7.500 call (PSNL270115C00007500) Interactive Stock Chart - Yahoo Finance
Yahoo! Finance Canada · 2026-10-20 -
Tracking Cathie Wood: Buying CoreWeave and Precision Medicine, Selling Personalis and Shopify
Moomoo · 2026-10-20 -
Personalis (PSNL) Stock Looks Richly Valued As Shares Surge 14x In 3 Years
Yahoo · 2026-10-20
No headlines in this category right now — try “All”.